PhilipAPhilipMD

PubMed

• Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma - analysis from SWOG S1505.
  Boutin, R., Kim, J., Beg, M., Wade, J., Guthrie, K., Chiorean, E., Ahmad, S., Lowy, A., Sohal, D., Lenchik, L., Wang-Gillam, A., Philip, P., Chang, V.> ;Journal of Gastrointestinal Surgery. 2024 Mar 1
• 1 citations
  Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations.
  Khushman, M., Toboni, M., Xiu, J., Manne, U., Farrell, A., Lou, E., Shields, A., Philip, P., Salem, M., Abraham, J., Spetzler, D., Marshall, J., Jayachandran, P., Hall...> ;Clinical Cancer Research. 2024 Feb 13
• Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma.
  Max M Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, Yuqing Xue, Renee Chang, Devora Delman, Jesse Lee, Kajsa Affolter, Sean J Mulvihill, M Shaalan Beg, Andrea Wang-...> ;Gastroenterology. 2024 Jan 18
• andgene expression in colorectal cancer: comprehensive profiling and clinical value.
  Francesca Battaglin, Yasmine Baca, Joshua Millstein, Yan Yang, Joanne Xiu, Hiroyuki Arai, Jingyuan Wang, Fang-Shu Ou, Federico Innocenti, Shannon M Mumenthaler, Priya ...> ;Journal for Immunotherapy of Cancer. 2024 Jan 11
• Deciphering cellular plasticity in pancreatic cancer for effective treatments.
  Md Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, Bassel F El-Rayes, Herbert Chen, Philip A Philip, Asfar S Azmi> ;Cancer Metastasis Reviews. 2024 Mar 1
• Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.
  Md Hafiz Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya...> ;Clinical and Translational Medicine. 2023 Dec 1
• 51 citations
  Neoadjuvant therapy for pancreatic cancer.
  Christoph Springfeld, Matthew H G Katz, Philip A Philip, Theodore S Hong, Thilo Hackert, Markus W Büchler, John Neoptolemos, Cristina R Ferrone> ;Nature Reviews. Clinical Oncology. 2023 May 1
• 9 citations
  Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer.
  En Cheng, Qian Shi, Anthony F Shields, Andrew B Nixon, Ardaman P Shergill, Chao Ma, Katherine A Guthrie, Felix Couture, Philip Kuebler, Pankaj Kumar, Benjamin Tan, Smi...> ;JAMA Oncology. 2023 Mar 1
• Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis.
  Andrew M Fleming, Benjamin W Deschner, Forrest W Williard, Justin A Drake, Ari Vanderwalde, Joanne Xiu, Bradley G Somer, Danny Yakoub, Miriam W Tsao, Evan S Glazer, Pa...> ;Journal of Surgical Oncology. 2023 Apr 1
• 4 citations
  Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
  Sepideh Gholami, Sarah Colby, David P Horowitz, Katherine A Guthrie, Edgar Ben-Josef, Anthony B El-Khoueiry, Charles D Blanke, Philip A Philip, Lisa A Kachnic, Syed A ...> ;Annals of Surgical Oncology. 2023 Mar 1
• 2 citations
  ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers - Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
  Sepideh Gholami, Sarah Colby, David P Horowitz, Katherine A Guthrie, Edgar Ben-Josef, Anthony B El-Khoueiry, Charles D Blanke, Philip A Philip, Lisa A Kachnic, Syed A ...> ;Annals of Surgical Oncology. 2023 Mar 1
• 20 citations
  Adjuvant-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial.
  Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, Jordan Winter, Do-Youn Oh, Chung-Pin Li, Giampaolo Tortora, Heung-Moon Chang, Charles D Lopez, Tanios Bekaii-Saab, A...> ;Journal of Clinical Oncology. 2023 Apr 10
• 3 citations
  Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy.
  Husain Yar Khan, Mandana Kamgar, Amro Aboukameel, Sahar Bannoura, Brian Y Chung, Yiwei Li, Mohammed Najeeb Al Hallak, Philip A Philip, Susan Tsai, Sanjeev Luther, Will...> ;Advances in Radiation Oncology. 2022 Nov 9
• 2 citations
  Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexia.
  Md Hafiz Uddin, Ramzi M Mohammad, Philip A Philip, Asfar S Azmi, Irfana Muqbil> ;American Journal of Physiology. Cell Physiology. 2022 Dec 1
• 3 citations
  Aberrant transcription factors in the cancers of the pancreas.
  Md Hafiz Uddin, Md Najeeb Al-Hallak, Philip A Philip, Herbert Chen, Bassel El-Rayes, Asfar S Azmi> ;Seminars in Cancer Biology. 2022 Nov 1
• 40 citations
  Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma.
  Philip A Philip, Ibrahim Azar, Joanne Xiu, Michael J Hall, Andrew Eugene Hendifar, Emil Lou, Jimmy J Hwang, Jun Gong, Rebecca Feldman, Michelle Ellis, Phil Stafford, D...> ;Clinical Cancer Research. 2022 Jun 13
• 16 citations
  Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
  Alberto Puccini, Kelsey Poorman, Fabio Catalano, Andreas Seeber, Richard M Goldberg, Mohamed E Salem, Anthony F Shields, Martin D Berger, Francesca Battaglin, Ryuma To...> ;Oncogene. 2022 Jun 1
• 4 citations
  A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
  Marcus S Noel, Semmie Kim, Marion L Hartley, Steve Wong, Vincent J Picozzi, Harry Staszewski, Dae Won Kim, Jan M Van Tornout, Philip Agop Philip, Vincent Chung, Allyso...> ;Cancer Medicine. 2022 Nov 1
• 8 citations
  Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers.
  Husain Yar Khan, Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md Hafiz Uddin, Rachel Sexton, Sahar Bannoura, Yousef Mzannar, Mohammed Najeeb Al-Hallak, Steve Kim, Rafic...> ;Cancer Research Communications. 2022 May 1
• 2 citations
  Classification of early-stage colon cancer with Immunoscore: clinical evidence and case studies.
  Suayib Yalcin, Philip A Philip, Ilias Athanasiadis, Shouki Bazarbashi, Ali Shamseddine> ;Future Oncology. 2022 Feb 1
• Preferences and Attitudes of Cardiologists in Management of Patients with Cancer.
  Ibrahim Azar, Stephani Wang, Vikram Dhillon, Jacqueline Kenitz, Dawn Lombardo, Roderick Deano, Syed Mahmood, Hirva Mamdani, Anthony F Shields, Philip Agop Philip, Mich...> ;Palliative Medicine Reports. 2022 Jan 1
• 2 citations
  Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers.
  Michael Cerniglia, Joanne Xiu, Axel Grothey, Michael J. Pishvaian, Yasmine Baca, Jimmy J. Hwang, John L. Marshall, Ari M. Vanderwalde, Anthony F. Shields, Heinz-Josef ...> ;Molecular Cancer Therapeutics. 2021 Nov 1
• 7 citations
  Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients.
  Alberto Puccini, Andreas Seeber, Joanne Xiu, Richard M. Goldberg, Davide Soldato, Axel Grothey, Anthony F. Shields, Mohamed E. Salem, Francesca Battaglin, Martin D. Be...> ;NPJ Precision Oncology. 2021 Oct 27
• 6 citations
  High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
  Amr Mohamed, Renjian Jiang, Philip A. Philip, Maria Diab, Madhusmita Behera, Christina Wu, Olatunji B. Alese, Walid L. Shaib, Tyra M. Gaines, Glen G. Balch, Bassel F. ...> ;Frontiers in Oncology. 2021 Oct 25
• Pancreatic cancer: why we must be optimistic?
  Philip A. Philip> ;Cancer Metastasis Reviews. 2021 Oct 6
• Join now to see all

Journal Articles

• Accomplishmants in 2008 in the treatment of metastatic pancreatic cancer.  
  Heinemann V, Philip PA, Pelzer U, Gastrointestinal Cancer Research, 3(5 supplement 2): S43-S47
• Defining New Paradigms for the Treatment of Pancreatic Cancer.  
  Almhanna K, Philip PA, Curr Treat Options Oncol. 2011 Jun; 12(2):111-25
• Combining sorafenib with chemoembolization for hepatocellular cancer.  
  Choi, M, Critchfield J, Philip P, Community Oncology. 2011 May 8(5):216-19
• A Rapid Method for the Determination of Acetylation Phenotype Using Dapsone.  
  Philip, P.A., Roberts, M.S., Rogers, H.J, British Journal of Clinical Pharmacology. 17:465-69, 1984
• Genetically Determined Debrisoquine Oxidation Capacity in Bladder Cancer.  
  Cartwright, R.A, Philip, P.A., Rogers H.J., Glashan, R.W, Carcinogenesis. 5: 1191-92, 1984
• Influence of Age, Sex and Body Weight on the Dapsone Acetylation Phenotype.  
  Philip, P.A., Gayed, S.L., Roger, H.J., Crome, P, British Journal of Pharmacology. 23:709-713, 1987
• Curable Metastatic Cancer in Young Women.  
  Ledermann, J.A., Crawford, S.M., Philip, P.A., Bagshawe, K.D, British Medical Journal. 295: 399-452, 1987
• Acetylator Status and its Relationship to Breast Cancer and Other Diseases of the Breast.  
  Philip, P.A., Rogers, H.J., Millis, R.R., Rubens, R.D., Cartwright, R.A, European Journal of Cancer and Clinical Oncology. 23:1701-06, 1987
• Acetylation and Oxidation Phenotypes in Malignant Lymphoma.  
  Philip, P.A., Rogers, H.J., Harper, P.G, Cancer Chemotherapy and Pharmacology. 20:235:238, 1987
• Determination of Debrisoquine Metabolic Ratio From Hourly Urine Collections in Healthy Volunteers.  
  Philip, P.A., James, C.A., Rogers, H.J, British Journal of Clinical Pharmacology. 24:827- 29, 1987
• Polymorphic N-acetylation Capacity in Lung Cancer.  
  Philip, P.A., Fitzgerald, D.L., Cartwright, R.A., Peake, M.D., Rogers, H.J, Carcinogenesis. 9:491-3, 1988
• Relationship Between Ifosfamide Plasma Clearance and the Debrisoquine Oxidation Status.  
  Philip, P.A., James, C.A., Lewis, L.D., Rogers, H.J, Cancer Chemotherapy and Pharmacology. 22:321-24, 1988
• Bone Disease in Testicular and Extragonadal Germ Cell Tumors.  
  Hitchins, R.N., Philip, P.A., Wignall, B., Newlands, E.S., Begent, R.H.J., Rustin, G.J.S., Bagshawe, K.D, British Journal of Cancer. 58:793-96, 1988
• Effect of Cancer Chemotherapy on Dapsone N-acetylation in Man.  
  Philip, P.A., Rogers, H.J, Cancer Chemotherapy and Pharmacology. 23:395-96, 1989
• The Influence of Cimetidine on Debrisoquine 4-Hydroxylation in Extensive Metabolizers.  
  Philip, P.A., James, C.A., Rogers, H.J, European Journal of Clinical Pharmacology. 36:319-21, 1989
• Respiratory Failure Due to Choriocarcinoma: A Study of 103 Dyspnoeic Patients.  
  Kelly, M.P., Rustin, G.J.S., Ivory, C., Philip, P.A., Bagshawe, K.D, Gynaecologic Oncology. 38:149-154, 1990
• In Vivo Uptake of 131I-5-Iodo-2-Deoxyuridine by Malignant Tumors in Man.  
  Philip, P.A., Bagshawe, K.D., Searle, F., Newlands, E.S., Begent, R.H.J., Adam, T, British Journal of Philip A. Cancer. 63:134-35, 1991
• Convulsions and Cortical Blindness Following Therapy with Cisplatin.  
  Philip, P.A., Carmichael, J., Harris, A.L, British Medical Journal. 302:416, 1991
• Weekly Etoposide, Methotrexate, and Actinomycin D, Alternating with Cyclophosphamide Plus Vincristine (EMA/CO); A Phase II Study in Advanced Gastric Carcinoma.  
  Philip, P.A., Rustin, G.J.S., Ledermann, J.A., Begent, R.H.J., Bagshawe, K.D, Clinical Oncology. 3:214-16, 1991
• A Phase I Study on the Reversal of Multidrug Resistance (MDR) in Vivo: Nifedipine Plus Etoposide.  
  Philip, P.A., Joel, S., Monkman, S.C., Dolega-Ossowski, E., Tonkin, K., Carmichael, J., Idle, J.R., Harris, A.L, British Journal of Cancer. 65:267-270, 1992
• Phase I Study of Intravenous 4-Hydroxyanisole.  
  Rustin, J.R., Stratford, M.R., Lamont, A., Bleehen, N., Philip, P.A., Howells, N., Watfa, R.R., Slack, J.A, European Journal of Cancer. 28A(8/9): 1362-64, 1992
• High-dose Tamoxifen as an Enhancer of Etoposide Cytotoxicity. Clinical Effects and In Vitro Assessment in P-Glycoprotein Expressing Cell Lines.  
  Stuart, N.S.A., Philip, P.A., Harris, A.L., Tonkin, K., Houlbrook, S., Kirk, J., Lien, E.A., Carmichael, J, British Journal of Cancer. 66:833-39, 1992
• Hormonal Treatment of Pancreatic Carcinoma: A Phase II Study of LHRH Agonist Goserelin Plus Hydrocortisone.  
  Philip, P.A., Carmichael, J., Tonkin, K., Buamah, P.K., Britton, J., Dowsett, M., Harris, A.L, British Journal of Cancer. 67:379-82, 1993
• The Influence of High Dose Hydroxyurea on the Incorporation of 5-Iodo-2-Deoxyuridine (IUdR) by Human Bone Marrow and Tumor Cells In Vivo.  
  Philip, P.A., Kaklamanis, L., Carmichael, J., Tonkin, K., Morrison, H., Gatter, K., Harris, A.L, British Journal of Cancer, 67:644-49, 1993
• A Phase I Study of the Left-Shifting Agent BW12C79 Plus Mitomycin C and the Effect on the Skeletal Muscle Metabolism Using 31P Magnetic Resonance Spectroscopy.  
  Philip, P.A., Campbell, C.H., Carmichael, J., Rea, D., Mitchell, K., Taylor, D.J., Stuart, N.S.A, Dennis, I., Rajagopalan, B., Ganesan, T., Radda, K., Harris, A.L, Cancer Research. 53:5649-53, 1993
• Join now to see all

Books/Book Chapters

• Oxford Textbook of Medicine. 
  Chapter: Malignant Disease in Pregnancy 
  Page 1806 - 1808Philip, P.A., Harris, A.LEditors: Weatherall D., Ledingham J.G.G., Warell D.A.Oxford University Press, OxfordEdition 3,
• Treatment of Cancer. 
  Chapter: Drug Resistance 
  Page 109 - 119Talbot, D.C., Philip, P.AEditors: Price P. and Sikora K.Chapman and Hall, LondonEdition 3,
• Medical Oncology a Comprehensive Review. 
  Chapter: Gastric Cancer 
  Page 235 - 246Philip, P.A., Ajani, JEditors: Richard Pazdur.PRR, Huntington, New York
• Medical Oncology, a Comprehensive Review. 
  Chapter: Prostate Cancer 
  Page 419 - 432Philip, P.A., Milliken, REditors: Richard Pazdur.PRR, Huntington, New York
• Medical Oncology, a Comprehensive Review. 
  Chapter: Esophageal Cancer 
  Page 225 - 234Philip, P.A., Ajani, JEditors: Richard Pazdur.PRR, Huntington, New York
• Genetic Diagnosis in Medicine. 
  Chapter: Molecular Biology in the Diagnosis, Follow-up and Therapeutic Evaluation of Colorectal Cancer 
  Philip, P.AEditors: J. Garcia-Foncillas, M.E. Armengod, J.M. Echevarria, A. Blasbond.University of Navarra Press, Pamplona
• Melanoma: Biologically Targeted Therapeutics. 
  Chapter: Biochemotherapy of Melanoma 
  Page 259 - 285Flaherty, L.E., Philip, P.AEditors: Ernest C Borden.Humana Press Inc, Totowa, New Jersey
• Pancreatic Cancer. 
  Chapter: Pitfalls in Clinical Trials and Future Directions 
  Page 723 - 731Philip, P. A., Heilbrun, L. K., Abrams, JSpringer Science
• Chemotherapy: Concepts, Mechanisms, and New Targets for Chemotherapy. 
  Chapter: Potential for Protein Kinase C Inhibitors in Cancer Therapy 
  Page 3 - 27Philip, P.A., Harris, A.LEditors: FM Muggia.Kluwer Academic Publishers, Boston, MA
• Encyclopedia of Cancer. 
  Chapter: Erlotinib 
  El-Rayes BF, Gadgeel S, Ali S, Philip PA, Sarkar FHSpringer, Berlin
• Join now to see all

Abstracts/Posters

• Perineural Invasion in Pancreatic Adenocarcinoma.
  Feng, J., Vaitkevicius, V.K., Shields, A.F., Philip, P.A., Adsay, V, Modern Pathology, 13(1), #1075
• Phase II Study of Doxorubicin, Docetaxel, and 5-Fluorouracil (FAT) in Patients with Locally Advanced Breast Cancer.
  Philip, P.A., Pernick, N.L., Vaishampayan, U., Simon, M., LoRusso, P., Chaplen, Biernat, L., Flaherty, L, Proceedings of ASCO
• Expression of Cytochrome p-450 Enzymes and Glutathione S-Transferase Pi in Tumoral Tissue From Patients with Head and Neck Cancers and its Relationship to the Tumoral ...
  Philip, P.A., Ensley, J. Heilbrun, L., Ali, S, Proceedings of AACR
• Perineural Invasion in Pancreatic Adenocarcinoma.
  Feng, J., Vaitkevicius, V., Shields, A., Philip, P., Adsay, V, Proceedings of 89th Annual Meeting, United States and Canadian Academy of Pathology, New Orleans
• Phase II Study of Gemcitabine, 5-Fluorouracil and Cisplatin in Patients With Advanced Pancreatic Cancer.
  Philip, P.A., Shields, A.F., Zalupski, M.M., Foster, B., Arlauskas, P., Adsay, V., Vaitkevicius, V.K, Pancreas, 4(21)
• FAS and FAS Ligand Expression in Pancreatic Adenocarcinoma.
  Pernick, N.L., Sarkar, F., Arlauskas, P.L., Philip, P.A., Shields, V.K., Vaitkevicius, V.K., Adsay, V, Pancreas, 4(21)
• Expression of Cytochrome P-450 Enzymes and Glutathione S-transferase P1 in Peritumoral Tissue From Patients with Head and Neck Cancers and its Relationship to the Tumo...
  Philip, PA, Ensley, J., Heilbrun, L., Ali, S, Proceedings of the Annual Meeting of the AACR, San Francisco
• Use of [18F]FLT for breast cancer imaging.
  Dohmen, B.M., Shields, A.F., Dittmann H, Fersis N, Eschmann SM, Philip P, Reimold M, Machulla HJ, Bares, Proceedings of the Society of Nuclear Medicine Meeting, Toronto
• A Single Institution Experience with Concurrent Capecitabine and Radiation Therapy in Gastrointestinal Malignancies.
  E. Ben-Joseph, E., Vaishampayan, U.N., Vaitkevicius, V.K., Levin, K..J., Philip, P.A., Shields, A.F, Proceedings of ASCO, Volume 20, Abst 2324
• Gemcitabine, Cisplatin, and 5-Fluorouracil in Advanced Pancreas Cancer.
  Philip, P.A., Shields, A.F., Zalupski, M., El-Rayes, B., Adsay, V., Heilbrun, L., Arlauskas, P.L., Vaitkevicius, V.K, Proceedings of ASCO, Volume 20, Abst 2341
• Flavopiridol Sensitizes Human Breast Cancer Cells to Gemcitabine.
  Philip, P.A., Shadan, Ali, Kraut, M.J., Sarkar, F, Annual Meeting of the American Association for Cancer Research
• Protein Kinases C Isozymes are Differentially Expressed in Human Breast Carcinoma.
  Al-Sukhun, S.A., Ali, S., Heilbrun, L., Lababidi, S., Philip, P.A, Proceedings of the American Association of Cancer Research
• Phase II Study of Gemcitabine, Cisplatin and Infusional 5-Fluorouracil in Patients with Metastatic Pancreatic Cancer.
  Philip, P.A., Zalupski, M., El-Rayes, B., Adsay, V., Heilbrun, L., Vaitkevicius, V.K., Shields, A.F, Proceedings of the American Society for Clinical Oncology
• A new method of dose modification using a computerized decision support system to accurately predict the contribution of each drug to the toxicity of chemotherapy regi...
  O Kucuk, J McMichael, A Hatfield, M Holmes, H Razook, N Yousif, M Kraut, P Philip, A Shields, J Abrams, Proceedings of the American Society of Clinical Oncology
• Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated with Preoperative Chemotherapy Predicts Breast Cancer Outcome.
  L.A. Newman, N.L. Pernick, P. Philip, K. Carolin, D. Bouwman, M. Kosir, M. White and D.W. Visscher, Annals of Surgery
• A phase I study of flavopiridol and docetaxel.
  B. Patel, B. F. El-Rayes, S. M. Gadgeel, P. Lorusso, P. A. Philip, Proceedings of the American Society of Clinical Oncology (ASCO), #932
• A phase I study of the protein kinase C modulator bryostatin-1 and gemcitabine.
  D. Ibrahim, B. F. El-Rayes, S. M. Gadgeel, P. Lorusso, P. A. Philip, Proceedings of the American Society of Clinical Oncology (ASCO), #930
• Protein kinase C (PKC): A target for therapy in pancreatic cancer.
  B. F. El-Rayes, S. Ali, F. Sarkar, P. A. Philip, Proceedings of the American Society of Clinical Oncology (ASCO), #1091
• Erlichman Tolerability of OSI-774 (Tarceva) in locally advanced or metastatic hepatocellular cancer (HCC) and biliary (BILI) carcinomas: an interim report.
  P. A. Philip, S. M. Geyer, J. P. Thomas, H. C. Pitot, R. Donehower, G. P. Kim, J. Picus, T. R. Fitch, M. R. Mahoney, C, Proceedings of the American Society of Clinical Oncology (ASCO), #1461
• Proceedings of the Molecular Targets and Cancer Therapeutics international conference.
  P. A. Philip, M. R. Mahoney, J. P. Thomas, H.C. Pitot, R. Donehower, G. P. Kim, J. Picus, T. R. Fitch, S. M. Geyer, C. Erlichman, n/a
• OSI-774 (Tarceva) in patients (pts) with unresectable or metastatic hepatocellular carcinoma (HCC): A multi-center Phase 2 Consortium (P2C) study.
  P. A. Philip, M. R. Mahoney, J. P. Thomas, H.C. Pitot, R. Donehower, G. P. Kim, J. Picus, T. R. Fitch, S. M. Geyer, C. Erlichman, Proceedings of the Molecular Targets and Cancer Therapeutics international conference
• Capecitabine is safe and tolerable in combination with radiation therapy in breast cancer.
  Vishnubhotla, PS, Alsukhn S, Washington T, Freidman L, Flaherty L, Simon B, Yu B, Philip PA, Breast Cancer Research and Treatment, Vol 82, Suppl 1, A169
• A Phase II trial of full-dose gemcitabine with concurrent radiation therapy in patients with resectable or unresectable non-metastatic pancreatic cancer.
  McGinn CJ, Talamonti MS, Small W, Freedman GM, Berlin J, Kinsella TJ, Philip PA, Zalupski MM, Mulcahy MF, Meropol NJ, Chakraverthy A, Brell J, Balter JM, Normolle D, B..., Proceedings of 2004 Gastrointestinal Cancers Symposium, Ab #96, page 89
• Targeting the epidermal growth factor receptor (EGFR) and cyclooxygenase 2 (COX-2) pathways in pancreatic cancer.
  El-Rayes, FB, Ali S, Sarkar F, Philip PA, Proceedings of 2004 Gastrointestinal Cancers Symposium, Ab #126, page 104
• Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
  Ben-Josef, Shields A, Vaishampayan U, Vaitkevicius V, McDermott P, Burmeister J, Bossenberger T, Philip PA, Proceedings of 2004 Gastrointestinal Cancers Symposium, Ab #163, page 122
• Join now to see all

Lectures

• Expression of Xenobiotic-Metabolizing Enzymes in Tonsilar Tissues. 
  Institute of Chemical Toxicology, Detroit, MI
• Mechanisms of Drug Resistance in Human Breast Cancer. 
  Breast Multidisciplinary Conference. Detroit, MI
• Novel Therapies in Upper GI Cancers. 
  CBCE, Newport Beach, CA
• Advances in Colo-Rectal Cancer. 
  Harper Hospital, Detroit, MI
• Drug-Metabolizing Enzymes. 
  Mechanisms of Drug Resistance Group, Barbara Ann Karmanos Cancer Institute, Detroit, MI
• Pancreas Cancer: are we doing better? 
  World Oncology Congress, San Francisco, CA
• Pancreatic Cancer. 
  Multiple Loactions, 1998, 2000, 2001, 2004, 2005, 2006, 2008
• Role of Cytochrome P450 3A4 Enzyme in the Pharmacogenetics of Cyclophosphamide. 
  Kresge Eye Institute, Detroit, MI
• Management of Liver Metastases in Colorectal Cancer. 
  VA Hospitals Symposium, Alexandria, VA
• Mechanisms of Drug Resistance Group. 
  Karmanos Cancer Institute
• Pancreatic and Gastric Cancers. 
  GI Symposium, Bangkok, Thailand
• Advances in the Therapy of Pancreatic Cancer. 
  Department of Medicine, Hutzel Hospital
• Angiogenesis as a target for cancer therapy. 
  Cancer Center, University of Alabama (UAB), Birmingham, AL
• Bryostatin and Gemcitabine. 
• Locally advanced Pancreas Cancer. 
  ASTRO annual meeting, Los Angeles, CA
• Phase II Study of Gemcitabine and Cisplatin. 
  Pancreas Group at Karmanos Cancer institute
• Advances in Pancreas Cancer. 
  GI Symposium, San Diego, CA, 2007, Arlington, VA, 2007
• Carcinoid tumors. 
  Annual GI Symposium of KCI, Troy, MI
• Updates on the Treatment of Pancreas Cancer. 
  Drug Discovery Program, Karmanos Cancer Institute
• Metastatic pancreas Cancer. 
  State of the Science meeting in Pancreas Cancer, Bethesda, MD
• Pitfalls of Clinical Trials in Pancreas Cancer. 
  State of the Science meeting in Pancreas Cancer, Bethesda, MD
• Karmanos Specific Treatments for Gastro-Esophageal Junction and Gastric Cancer. 
  ProMedica Cancer Institute Symposium, Toledo, OH
• Role of Carcinogen Metabolizing Enzymes in Susceptibility and Response to Therapy. 
  Breast Program, Karmanos Cancer Institut
• Treatment of Oligometastases. 
  ProMedica Cancer Institute Symposium, Toledo, OH
• The VEGF Pathway as a Therapeutic Target in Cancer. 
  Beaumont Cancer Center, Royal Oak, MI
• Join now to see all

Other

• Improvements in Gastric Cancer Therapy Options. 
  Philip, PA, Medscape Conference Coverage
  http://www.medscape.com/viewarticle/457605
• Update on the GI ASCO Symposium, Pancreas Cancer. 
  Philip, PA
  http://www.medscape.com/viewarticle/468972
• Key Practical Strategies in Pancreatic Cancer: Improving Treatment Disparities and Clinical Trial Accrual. 
  Philip PA, MedscapeCME Oncology
  http://www.medscape.com
• Top Oncology Stories for 2010, Pancreas Cancer. 
  Philip PA, Lee Schwartzberg and Axel Grothey
• Current Strategies in Previously Untreated Patients with Advanced Colorectal Cancer. 
  Philip PA, Physicians Education Resource, 7(3): 3-6, 2003
• Experience with Docetaxel in the Treatment of Gastric Cancer. 
  Philip PA, Seminars in Oncology. 32(suppl 4): S24-S38
• Liver Directed Therapies in Hepatocellular Cancer. 
  Choi M and Philip PA, Community Oncology
• Targeted Therapies for Pancreatic Cancer. 
  Philip PA, Gastrointestinal Cancer Research, 2(4): S16-S19
• Join now to see all